Therapeutic management of laryngeal cancer. Results of a study of 356 patients from the Cancer Registry of the Somme, France

Acta Oto-Laryngologica

Volumn 125, Issue 12, 2005, Pages 1323-1326

  Ayache, Stéphane ^a  

^a Service ORL CCF   (France)

Author keywords

Cancer registry; Laryngeal cancer; Therapeutic management

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGE; AGED; ARTICLE; BONE METASTASIS; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER STAGING; CANCER SURGERY; CONTROLLED STUDY; ESOPHAGUS CANCER; FEMALE; FRANCE; HUMAN; JAW CANCER; KAPLAN MEIER METHOD; LARYNGECTOMY; LARYNX CANCER; LUNG METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; OROPHARYNX CANCER; PATIENT CARE; PATIENT SELECTION; POPULATION; PRIORITY JOURNAL; PROGNOSIS; RECURRENT CANCER; RETROSPECTIVE STUDY; SEX; STATISTICAL SIGNIFICANCE; STUDENT T TEST; SURVIVAL RATE; SURVIVAL TIME;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; COMBINED MODALITY THERAPY; FEMALE; FRANCE; HUMANS; INCIDENCE; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROBABILITY; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEX DISTRIBUTION; SURVIVAL ANALYSIS;

EID: 28444464071     PISSN: 00016489     EISSN: None     Source Type: Journal    
DOI: 10.1080/00016480410017648     Document Type: Article

References (14)

1. Berrino F, Gatta G. Variation in survival of patients with head and neck cancer in Europe by the site of origin of the tumours. Eur J Cancer 1998;34:2154-61.
2. Les cancers du larynx en France. Eléments d'épidé miologie descriptive et estimation de l'incidence nationale. Bull Cancer 2004; In press.
3. Suzuki H, Hasegawa T, Kim Y. Results of treatment of laryngeal cancer. Acta Otolaryngol Suppl (Stockh) 1994;511:186-91.
4. Nguyen-Tan PF, Le QT, Goffinet KK. Treatment results and prognostic factors of advanced T3-T4 laryngeal carcinoma: the University of California, San Francisco (UCSF) and Stanford University Hospital (SUH) experience. Int J Radiat Oncol Biol Phys 2001;50:1172-80.
5. Sankanarayanan R, Ramanakumar AV, Yeole BB. Survival from glottic and supraglottic laryngeal carcinoma in Mumbai (Bombay), India. Oral Oncol 2003;39:656-63.
6. Golen M, Skladowski K, Maciejewski B. Comparative estimation of cure rates for supraglottic and glottic cancer in radiotherapy. Neoplasma 1999;46:66-71.
7. Coebergh JWW, van der Heijden LH, Janssen-Heijnen MLG. Cancer incidence and survival in the Southeast of the Netherlands. 1955-1994. Eindhoven Cancer Registry, 1995.
8. Lefebvre JL, Buisset E, Coche-Dequent B. Epilarynx: pharynx or larynx? Head Neck 1995;17:377-81.
9. Mak-Kregar S, Hilgers FJ, Levendag PC. A nation-wide study of the epidemiology, treatment and survival of oropharyngeal carcinoma in The Netherlands. Eur Arch Otorhinolaryngol 1995;252:133-8.
10. Mork J, Glattre E. Squamous cell carcinoma of the head and neck in Norway, 1953-92: an epidemiologic study of a low-risk population. Cancer Causes Control 1998;9:37-48.
11. Spector JG, Sessions DG, Perez CA. Stage I (T1 N0 M0) squamous cell carcinoma of the laryngeal glottis: therapeutic results and voice preservation. Head Neck 1999;21:707-17.
12. Scola B, Fernandez-Vega M, Ramirez C. Management of cancer of the supraglottis. Otolaryngol Head Neck Surg 2001;124:195-8.
13. Spriano G, Antognoni P, Tordiglione M. Conservative management of T1-T2 supraglottic cancer: a retrospective study. Am J Otolaryngol 1997;18:299-305.
14. Hinerman RW, Mendenhall WM, Robbins KT. Carcinoma of the supraglottic larynx: treatment results with radiotherapy alone or with planned neck dissection. Head Neck 2002;24:456-67.